Scientists launch study to unlock secrets of rare cancer EHE
NCT ID NCT06680401
First seen Apr 02, 2026 · Last updated Apr 29, 2026 · Updated 4 times
Summary
This study is for people with a rare cancer called epithelioid haemangioendothelioma (EHE). Researchers will collect medical information and blood samples to look for natural substances (biomarkers) that may help predict how the disease will progress. They will also create lab-grown models of the cancer to test new treatments. The goal is to better understand EHE and find better ways to treat it in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NATURAL HISTORY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fondazione IRCCS IstitutoNazionale dei Tumori
RECRUITINGMilan, 20133, Italy
Contact Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.